German biotech MODAG won for pairing a CE-marked diagnostic with a drug candidate that targets the same protein.
A day is a long time to study a donated human brain. Bexorg thinks it’s still too short. On 7 October, the Connecticut-based ...
Adjusting for how advanced patients’ disease was at the start lifts the Phase 2 result. The method was added after the trial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results